EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Role of Adjuvant Radiotherapy for Early‐Stage Oral Cavity Cancer With Minor Adverse Features; A Single Institute Experience

Eyal Yosefof iD, Nofar Edri iD, Noga Kurman, Gideon Bachar, Thomas Shpitzer, Aviram Mizrachi, Aron Popovtzer

Head & Neck · 2025

DOI: 10.1002/hed.28093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Eyal Yosefof und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Rabin Medical Center, Petah Tikva, Israel. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Tongue Neoplasms, Mouth Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The role of post‐operative radiotherapy (PORT) in early‐stage (T1‐T2N0M0) oral tongue squamous cell carcinoma (OTSCC) with minor adverse features (MAF) including perineural invasion (PNI) and poorly differentiated carcinoma (PDC) is not well described. We aimed to study the role of PORT among these patients.

Methods

A retrospective review of patients treated for early‐stage OTSCC between 2000 and 2022 in a tertiary‐care referral center while comparing patients treated by surgery and PORT with patients treated by surgery alone.

Results

One hundred fifty‐four patients were included and 36 (23.4%) received PORT. The PORT subgroup had a significantly higher rate of MAF. Survival rates were similar between the two sub‐groups. PORT demonstrated a trend toward improved overall survival (odds ratio = 0.406, p = 0.07). Patients with PNI or PDC treated with PORT experienced improved survival rates.

Conclusion

PORT has an important role when treating early‐stage OTSCC with MAF. It should be considered especially among patients with PNI or PDC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellTongue NeoplasmsMouth NeoplasmsHumansRetrospective StudiesMaleFemaleMiddle AgedRadiotherapy, AdjuvantAgedNeoplasm StagingNeoplasm InvasivenessAdultSurvival RateTreatment OutcomeAged, 80 and overSurvival Analysis

Stichwörter der Autor:innen

adjuvant radiotherapydisease free survivaldisease specific survivaloral squamous cell carcinomaoverall survival

Autor:innen und Institutionen

  • Department of Otolaryngology Head and Neck Surgery, Rabin Medical Center, Petah Tikva, Israel.
  • Institute of Oncology, Davidoff Center, Rabin Medical Center, Petach Tikva, Israel.
  • Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.

ORCID-Profile: Eyal Yosefof, Nofar Edri

Zitieren

APA

Yosefof, E., Edri, N., Kurman, N., Bachar, G., Shpitzer, T., Mizrachi, A., & Popovtzer, A. (2025). The Role of Adjuvant Radiotherapy for Early‐Stage Oral Cavity Cancer With Minor Adverse Features; A Single Institute Experience. Head & Neck. https://doi.org/10.1002/hed.28093

Vancouver

Yosefof E, Edri N, Kurman N, Bachar G, Shpitzer T, Mizrachi A, et al. The Role of Adjuvant Radiotherapy for Early‐Stage Oral Cavity Cancer With Minor Adverse Features; A Single Institute Experience. Head & Neck. 2025. doi:10.1002/hed.28093

BibTeX
@article{Yosefof2025,
  author = {Yosefof, Eyal and Edri, Nofar and Kurman, Noga and Bachar, Gideon and Shpitzer, Thomas and Mizrachi, Aviram and Popovtzer, Aron},
  title = {The Role of Adjuvant Radiotherapy for Early‐Stage Oral Cavity Cancer With Minor Adverse Features; A Single Institute Experience},
  journal = {Head & Neck},
  year = {2025},
  doi = {10.1002/hed.28093}
}
Kostenlos starten →